Clinical relevance of reduced bioavailability of rifampicin.
Article
Dans Anglais
| IMSEAR
| ID: sea-89296
ABSTRACT
Bioavailability (BA) of rifampicin (RMP) is a critical factor in successful treatment of tuberculosis. The BA of RMP can be reduced by pharmaceutical factors, patient factors and drug interactions. Failure of treatment and development of drug resistance are potential consequences of reduction in BA and it is necessary to understand and control the factors influencing BA of RMP.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Rifampicine
/
Tuberculose
/
Humains
/
Biodisponibilité
/
Interactions médicamenteuses
/
Antituberculeux
langue:
Anglais
Année:
1998
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS